カテゴリー： Market Monitor Global, 世界, 医療/バイオ

アンドロゲン受容体（AR）阻害剤の世界市場見通し2023年-2029年

◆英語タイトル：Androgen Receptor (AR) Inhibitor Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5649）

◆商品コード：MMG23JU5649
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：66
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Androgen Receptor (AR) Inhibitor Market 調査レポートは次の情報を含め、グローバルにおけるのアンドロゲン受容体（AR）阻害剤市場規模と予測を収録しています。・世界のアンドロゲン受容体（AR）阻害剤市場：売上、2018年-2023年、2024年-2029年
・世界のアンドロゲン受容体（AR）阻害剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のアンドロゲン受容体（AR）阻害剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ステロイド剤」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

アンドロゲン受容体（AR）阻害剤のグローバル主要企業は、Orion Corporation、 Pfizer、 Hengrui、 Bayer、 Schering-Plough、 Hinova Pharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、アンドロゲン受容体（AR）阻害剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のアンドロゲン受容体（AR）阻害剤市場：タイプ別、2018年-2023年、2024年-2029年
世界のアンドロゲン受容体（AR）阻害剤市場：タイプ別市場シェア、2022年
・ステロイド剤、非ステロイド剤

世界のアンドロゲン受容体（AR）阻害剤市場：用途別、2018年-2023年、2024年-2029年
世界のアンドロゲン受容体（AR）阻害剤市場：用途別市場シェア、2022年
・病院、診療所、その他

世界のアンドロゲン受容体（AR）阻害剤市場：地域・国別、2018年-2023年、2024年-2029年
世界のアンドロゲン受容体（AR）阻害剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるアンドロゲン受容体（AR）阻害剤のグローバル売上、2018年-2023年
・主要企業におけるアンドロゲン受容体（AR）阻害剤のグローバル売上シェア、2022年
・主要企業におけるアンドロゲン受容体（AR）阻害剤のグローバル販売量、2018年-2023年
・主要企業におけるアンドロゲン受容体（AR）阻害剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Orion Corporation、 Pfizer、 Hengrui、 Bayer、 Schering-Plough、 Hinova Pharma

*************************************************************

・調査・分析レポートの概要
アンドロゲン受容体（AR）阻害剤市場の定義
市場セグメント
世界のアンドロゲン受容体（AR）阻害剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のアンドロゲン受容体（AR）阻害剤市場規模
世界のアンドロゲン受容体（AR）阻害剤市場規模：2022年 VS 2029年
世界のアンドロゲン受容体（AR）阻害剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのアンドロゲン受容体（AR）阻害剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のアンドロゲン受容体（AR）阻害剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ステロイド剤、非ステロイド剤
アンドロゲン受容体（AR）阻害剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
アンドロゲン受容体（AR）阻害剤の用途別グローバル売上・予測

・地域別市場分析
地域別アンドロゲン受容体（AR）阻害剤市場規模 2022年と2029年
地域別アンドロゲン受容体（AR）阻害剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Orion Corporation、 Pfizer、 Hengrui、 Bayer、 Schering-Plough、 Hinova Pharma
...

This report aims to provide a comprehensive presentation of the global market for Androgen Receptor (AR) Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Androgen Receptor (AR) Inhibitor. This report contains market size and forecasts of Androgen Receptor (AR) Inhibitor in global, including the following market information:
Global Androgen Receptor (AR) Inhibitor Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Androgen Receptor (AR) Inhibitor market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Steroids Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Androgen Receptor (AR) Inhibitor include Orion Corporation, Pfizer, Hengrui, Bayer, Schering-Plough and Hinova Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Androgen Receptor (AR) Inhibitor companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Androgen Receptor (AR) Inhibitor Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Androgen Receptor (AR) Inhibitor Market Segment Percentages, by Type, 2022 (%)
Steroids
Nonsteroidal
Global Androgen Receptor (AR) Inhibitor Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Androgen Receptor (AR) Inhibitor Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Androgen Receptor (AR) Inhibitor Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Androgen Receptor (AR) Inhibitor Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Androgen Receptor (AR) Inhibitor revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Androgen Receptor (AR) Inhibitor revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Orion Corporation
Pfizer
Hengrui
Bayer
Schering-Plough
Hinova Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Androgen Receptor (AR) Inhibitor, market overview.
Chapter 2: Global Androgen Receptor (AR) Inhibitor market size in revenue.
Chapter 3: Detailed analysis of Androgen Receptor (AR) Inhibitor company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Androgen Receptor (AR) Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Androgen Receptor (AR) Inhibitor Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Androgen Receptor (AR) Inhibitor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Androgen Receptor (AR) Inhibitor Overall Market Size
2.1 Global Androgen Receptor (AR) Inhibitor Market Size: 2022 VS 2029
2.2 Global Androgen Receptor (AR) Inhibitor Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Androgen Receptor (AR) Inhibitor Players in Global Market
3.2 Top Global Androgen Receptor (AR) Inhibitor Companies Ranked by Revenue
3.3 Global Androgen Receptor (AR) Inhibitor Revenue by Companies
3.4 Top 3 and Top 5 Androgen Receptor (AR) Inhibitor Companies in Global Market, by Revenue in 2022
3.5 Global Companies Androgen Receptor (AR) Inhibitor Product Type
3.6 Tier 1, Tier 2 and Tier 3 Androgen Receptor (AR) Inhibitor Players in Global Market
3.6.1 List of Global Tier 1 Androgen Receptor (AR) Inhibitor Companies
3.6.2 List of Global Tier 2 and Tier 3 Androgen Receptor (AR) Inhibitor Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Androgen Receptor (AR) Inhibitor Market Size Markets, 2022 & 2029
4.1.2 Steroids
4.1.3 Nonsteroidal
4.2 By Type – Global Androgen Receptor (AR) Inhibitor Revenue & Forecasts
4.2.1 By Type – Global Androgen Receptor (AR) Inhibitor Revenue, 2018-2023
4.2.2 By Type – Global Androgen Receptor (AR) Inhibitor Revenue, 2024-2029
4.2.3 By Type – Global Androgen Receptor (AR) Inhibitor Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Androgen Receptor (AR) Inhibitor Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application – Global Androgen Receptor (AR) Inhibitor Revenue & Forecasts
5.2.1 By Application – Global Androgen Receptor (AR) Inhibitor Revenue, 2018-2023
5.2.2 By Application – Global Androgen Receptor (AR) Inhibitor Revenue, 2024-2029
5.2.3 By Application – Global Androgen Receptor (AR) Inhibitor Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Androgen Receptor (AR) Inhibitor Market Size, 2022 & 2029
6.2 By Region – Global Androgen Receptor (AR) Inhibitor Revenue & Forecasts
6.2.1 By Region – Global Androgen Receptor (AR) Inhibitor Revenue, 2018-2023
6.2.2 By Region – Global Androgen Receptor (AR) Inhibitor Revenue, 2024-2029
6.2.3 By Region – Global Androgen Receptor (AR) Inhibitor Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Androgen Receptor (AR) Inhibitor Revenue, 2018-2029
6.3.2 US Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
6.3.3 Canada Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
6.3.4 Mexico Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Androgen Receptor (AR) Inhibitor Revenue, 2018-2029
6.4.2 Germany Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
6.4.3 France Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
6.4.4 U.K. Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
6.4.5 Italy Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
6.4.6 Russia Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
6.4.7 Nordic Countries Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
6.4.8 Benelux Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Androgen Receptor (AR) Inhibitor Revenue, 2018-2029
6.5.2 China Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
6.5.3 Japan Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
6.5.4 South Korea Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
6.5.5 Southeast Asia Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
6.5.6 India Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Androgen Receptor (AR) Inhibitor Revenue, 2018-2029
6.6.2 Brazil Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
6.6.3 Argentina Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Androgen Receptor (AR) Inhibitor Revenue, 2018-2029
6.7.2 Turkey Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
6.7.3 Israel Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
6.7.4 Saudi Arabia Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
6.7.5 UAE Androgen Receptor (AR) Inhibitor Market Size, 2018-2029
7 Androgen Receptor (AR) Inhibitor Companies Profiles
7.1 Orion Corporation
7.1.1 Orion Corporation Company Summary
7.1.2 Orion Corporation Business Overview
7.1.3 Orion Corporation Androgen Receptor (AR) Inhibitor Major Product Offerings
7.1.4 Orion Corporation Androgen Receptor (AR) Inhibitor Revenue in Global Market (2018-2023)
7.1.5 Orion Corporation Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Androgen Receptor (AR) Inhibitor Major Product Offerings
7.2.4 Pfizer Androgen Receptor (AR) Inhibitor Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Hengrui
7.3.1 Hengrui Company Summary
7.3.2 Hengrui Business Overview
7.3.3 Hengrui Androgen Receptor (AR) Inhibitor Major Product Offerings
7.3.4 Hengrui Androgen Receptor (AR) Inhibitor Revenue in Global Market (2018-2023)
7.3.5 Hengrui Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Androgen Receptor (AR) Inhibitor Major Product Offerings
7.4.4 Bayer Androgen Receptor (AR) Inhibitor Revenue in Global Market (2018-2023)
7.4.5 Bayer Key News & Latest Developments
7.5 Schering-Plough
7.5.1 Schering-Plough Company Summary
7.5.2 Schering-Plough Business Overview
7.5.3 Schering-Plough Androgen Receptor (AR) Inhibitor Major Product Offerings
7.5.4 Schering-Plough Androgen Receptor (AR) Inhibitor Revenue in Global Market (2018-2023)
7.5.5 Schering-Plough Key News & Latest Developments
7.6 Hinova Pharma
7.6.1 Hinova Pharma Company Summary
7.6.2 Hinova Pharma Business Overview
7.6.3 Hinova Pharma Androgen Receptor (AR) Inhibitor Major Product Offerings
7.6.4 Hinova Pharma Androgen Receptor (AR) Inhibitor Revenue in Global Market (2018-2023)
7.6.5 Hinova Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Androgen Receptor (AR) Inhibitor Market Opportunities & Trends in Global Market
Table 2. Androgen Receptor (AR) Inhibitor Market Drivers in Global Market
Table 3. Androgen Receptor (AR) Inhibitor Market Restraints in Global Market
Table 4. Key Players of Androgen Receptor (AR) Inhibitor in Global Market
Table 5. Top Androgen Receptor (AR) Inhibitor Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Androgen Receptor (AR) Inhibitor Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Androgen Receptor (AR) Inhibitor Revenue Share by Companies, 2018-2023
Table 8. Global Companies Androgen Receptor (AR) Inhibitor Product Type
Table 9. List of Global Tier 1 Androgen Receptor (AR) Inhibitor Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Androgen Receptor (AR) Inhibitor Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Androgen Receptor (AR) Inhibitor Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Androgen Receptor (AR) Inhibitor Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Androgen Receptor (AR) Inhibitor Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Androgen Receptor (AR) Inhibitor Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Androgen Receptor (AR) Inhibitor Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Androgen Receptor (AR) Inhibitor Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2024-2029
Table 30. Orion Corporation Company Summary
Table 31. Orion Corporation Androgen Receptor (AR) Inhibitor Product Offerings
Table 32. Orion Corporation Androgen Receptor (AR) Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 33. Orion Corporation Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Androgen Receptor (AR) Inhibitor Product Offerings
Table 36. Pfizer Androgen Receptor (AR) Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Hengrui Company Summary
Table 39. Hengrui Androgen Receptor (AR) Inhibitor Product Offerings
Table 40. Hengrui Androgen Receptor (AR) Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 41. Hengrui Key News & Latest Developments
Table 42. Bayer Company Summary
Table 43. Bayer Androgen Receptor (AR) Inhibitor Product Offerings
Table 44. Bayer Androgen Receptor (AR) Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 45. Bayer Key News & Latest Developments
Table 46. Schering-Plough Company Summary
Table 47. Schering-Plough Androgen Receptor (AR) Inhibitor Product Offerings
Table 48. Schering-Plough Androgen Receptor (AR) Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 49. Schering-Plough Key News & Latest Developments
Table 50. Hinova Pharma Company Summary
Table 51. Hinova Pharma Androgen Receptor (AR) Inhibitor Product Offerings
Table 52. Hinova Pharma Androgen Receptor (AR) Inhibitor Revenue (US$, Mn) & (2018-2023)
Table 53. Hinova Pharma Key News & Latest Developments
List of Figures
Figure 1. Androgen Receptor (AR) Inhibitor Segment by Type in 2022
Figure 2. Androgen Receptor (AR) Inhibitor Segment by Application in 2022
Figure 3. Global Androgen Receptor (AR) Inhibitor Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Androgen Receptor (AR) Inhibitor Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Androgen Receptor (AR) Inhibitor Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Androgen Receptor (AR) Inhibitor Revenue in 2022
Figure 8. By Type - Global Androgen Receptor (AR) Inhibitor Revenue Market Share, 2018-2029
Figure 9. By Application - Global Androgen Receptor (AR) Inhibitor Revenue Market Share, 2018-2029
Figure 10. By Type - Global Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Androgen Receptor (AR) Inhibitor Revenue Market Share, 2018-2029
Figure 12. By Application - Global Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Androgen Receptor (AR) Inhibitor Revenue Market Share, 2018-2029
Figure 14. By Region - Global Androgen Receptor (AR) Inhibitor Revenue Market Share, 2018-2029
Figure 15. By Country - North America Androgen Receptor (AR) Inhibitor Revenue Market Share, 2018-2029
Figure 16. US Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Androgen Receptor (AR) Inhibitor Revenue Market Share, 2018-2029
Figure 20. Germany Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 21. France Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Androgen Receptor (AR) Inhibitor Revenue Market Share, 2018-2029
Figure 28. China Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 32. India Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Androgen Receptor (AR) Inhibitor Revenue Market Share, 2018-2029
Figure 34. Brazil Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Androgen Receptor (AR) Inhibitor Revenue Market Share, 2018-2029
Figure 37. Turkey Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Androgen Receptor (AR) Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 41. Orion Corporation Androgen Receptor (AR) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Androgen Receptor (AR) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Hengrui Androgen Receptor (AR) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bayer Androgen Receptor (AR) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Schering-Plough Androgen Receptor (AR) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Hinova Pharma Androgen Receptor (AR) Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ アンドロゲン受容体（AR）阻害剤の世界市場見通し2023年-2029年(Androgen Receptor (AR) Inhibitor Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

アンドロゲン受容体（AR）阻害剤の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp